Erasca, Inc. (ERAS) stock

ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30

$15.66−0.12 (-0.76%)

Close on Nov 13, 2026Market cap $5.48BP/E –Yield 0.00%

Erasca profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Erasca has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?